Inhibition of IGF1R by Ceritinib Promotes Cell Growth Inhibition of PD-CSF-CTCs and Human BRAF V600E Melanoma Cells, Including Those That are Rendered Resistant to BRAF Inhibitors. This evidence concerns the gene BRAF and melanoma.